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Introduction: Fibromyalgia (FM) is characterized by persistent widespread pain, increased pain sensitivity and
tenderness. Muscle strength in women with FM is reduced compared to healthy women. The aim of this study was
to examine the effects of a progressive resistance exercise program on muscle strength, health status, and current
pain intensity in women with FM.
Methods: A total of 130 women with FM (age 22–64 years, symptom duration 0–35 years) were included in this
assessor-blinded randomized controlled multi-center trial examining the effects of progressive resistance group
exercise compared with an active control group. A person-centred model of exercise was used to support the
participants’ self-confidence for management of exercise because of known risks of activity-induced pain in FM.
The intervention was performed twice a week for 15 weeks and was supervised by experienced physiotherapists.
Primary outcome measure was isometric knee-extension force (Steve Strong®), secondary outcome measures were
health status (FIQ total score), current pain intensity (VAS), 6MWT, isometric elbow-flexion force, hand-grip force,
health related quality of life, pain disability, pain acceptance, fear avoidance beliefs, and patient global impression
of change (PGIC). Outcomes were assessed at baseline and immediately after the intervention. Long-term follow up
comprised the self-reported questionnaires only and was conducted after 13–18 months. Between-group and
within-group differences were calculated using non-parametric statistics.
Results: Significant improvements were found for isometric knee-extension force (p = 0.010), health status (p = 0.038),
current pain intensity (p = 0.033), 6MWT (p = 0.003), isometric elbow flexion force (p = 0.02), pain disability (p = 0.005),
and pain acceptance (p = 0.043) in the resistance exercise group (n = 56) when compared to the control group
(n = 49). PGIC differed significantly (p = 0.001) in favor of the resistance exercise group at post-treatment examinations.
No significant differences between the resistance exercise group and the active control group were found regarding
change in self-reported questionnaires from baseline to 13–18 months.
Conclusions: Person-centered progressive resistance exercise was found to be a feasible mode of exercise for women
with FM, improving muscle strength, health status, and current pain intensity when assessed immediately after the
intervention.
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Musculoskeletal pain has a negative impact on quality of
life and work capacity [1] for individuals and entails
large costs for society due to long-term sickness absence
[2, 3]. Fibromyalgia (FM) affects approximately 1–3 % of
the general population, and it is more common among
women and in older age [4, 5]. FM is characterized by
persistent widespread pain, increased pain sensitivity
and tenderness [6] and is associated with impaired phys-
ical capacity [7–9], activity limitations [10], fatigue, and
distress [6, 11].
The pain in FM is attributed to amplification of noci-
ceptive input due to central sensitization and impaired
central pain inhibition [12, 13]. Hypothetically, physical
deconditioning leads to enhanced muscle ischemia, in-
creasing peripheral sensitization and thus contributing
to the central sensitization [14]. Although the precise
etiology of FM is not known, physical deconditioning is
believed to contribute to the development of FM [15].
Muscle strength in women with FM has been reported
to be reduced by an average of 39 % compared to
healthy women [16]. Possible physiological explanations
for the reduced strength include structural changes in
muscle fibers [17], altered neuromuscular control mech-
anisms [18], impaired blood circulation [19], and distur-
bances in regulation of growth and energy metabolism
[20]. However, no differences in neuromuscular coordin-
ation was found in a study comparing exercising women
with FM to sedentary controls, and both groups im-
proved their motor unit activity during a resistance
exercise program [21]. This indicates that a reason for
reduced muscle strength in FM might be a low amount
of physical activity at such a level that is required to
maintain or improve muscle strength. Also a recent
study using accelerometers indicates that the amount of
physical activity at moderate and vigorous level is low
among patients with FM when compared to healthy in-
dividuals [22]. Activity-induced pain is a common fea-
ture in FM [23] and might be a reason why the patients
avoid activities and exercise, which could increase pain.
Current guidelines for patients with FM include recom-
mendations for aerobic exercise, such as brisk walking
and cycling, as an important part of long-term manage-
ment of FM [24, 25], as in several studies this mode of
exercise has been shown to improve general health and
physical function in patients with FM [26, 27]. Although
muscle deconditioning is known to increase the suscep-
tibility to microtrauma related to mechanical strain
during physical activities [28], few studies have evaluated
the effects of resistance exercise designed to improve
muscle strength in FM [15]. However they have docu-
mented promising effects of resistance exercise on muscle
strength, health status and pain, but the paucity of studies
implies a low quality of evidence [15]. Meta-analyses in aCochrane report of resistance exercise are based on one to
three trials [15], warranting further research to improve
confidence for estimated effects of resistance exercise for
patients with FM [15].
A possible reason for the paucity of studies evaluating
the effects of resistance exercise in FM is the risk of
increased pain during isometric muscle contraction [23].
However exercise-induced pain during progressive resist-
ance exercise might be avoided by gradual introduction to
heavier loads [29]. Furthermore a theory of person-
centeredness, which emphasizes active involvement of the
patient in planning the treatment, is suggested to enhance
the patient’s ability to manage health problems [30]. In the
present study, the details of the exercise program were
planned together with each patient, using the principles of
person-centeredness, to support each participant’s ability
to manage the exercise and the progress of it.
Relaxation therapy was chosen as an active control
intervention as it is often integrated in multidisciplinary
rehabilitation for patients with FM [24], rather than to
control for treatment as usual. There is little evidence of
the effects of relaxation therapy as an isolated therapy in
FM [31], but relaxation therapy is assumed to improve
overall wellbeing, thus providing a meaningful and in-
spiring therapy to control for the natural course and
some aspects of attention and expectations. Patients re-
cruited to the study were informed that the aim of the
study was to compare these two treatment modalities.
The aim of this study was to examine the effects of a pro-
gressive resistance exercise program using a person-
centered approach, on muscle strength, health status, and
current pain intensity in women with FM. Relaxation ther-
apy was selected as an active control intervention.
Methods
An assessor-blinded randomized controlled multicenter
trial examined the effects of progressive resistance group
exercise compared with an active control group. The
trial was registered with ClinicalTrials.gov identification
number: NCT01226784.
Recruitment
The recruitment started in 2010 and data collection was
completed at all sites (Gothenburg, Stockholm, and
Linköping) in 2013. Inclusion criteria were women aged
20–65 years, meeting the American College of Rheuma-
tology (ACR) 1990 classification criteria for FM [6].
Comorbidity as an exclusion criterion was defined by
anamnesis. Exclusion criteria were high blood pressure
(>160/90 mmHg), osteoarthritis (OA) in hip or knee,
confirmed by radiological findings and affecting activities
of daily life such as stair climbing or walking, other severe
somatic or psychiatric disorders, other dominating causes
of pain than FM, high consumption of alcohol (alcohol
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participation in a rehabilitation program within the past
year, regular resistance exercise or relaxation exercise
twice a week or more, inability to understand or speak
Swedish, and not being able to refrain from analgesics,
non-steroidal anti-inflammatory drugs (NSAID) or hyp-
notic drugs for 48 hours prior to examinations.
Women with FM were recruited by newspaper adver-
tisement in the local newspapers of three cities in Sweden
(Gothenburg, Stockholm, and Linköping). A total of 402
women with FM who notified their interest for participa-
tion in the study were telephone screened for possible eli-
gibility and informed about the study procedure. Out of
these, 177 women who were interested in participation
were referred for medical examination for further enroll-
ment, while 225 were not eligible for enrollment (for
details see Fig. 1). The 177 women were screened for eligi-
bility by an experienced physician to verify ACR 1990 cri-
teria for FM by means of a standardized interview and
palpation of tender points [6]. A total of 47 women were
found not eligible due to not meeting the inclusion criteria
(n = 28), or declining participation (n = 19). One-hundred
and thirty women with FM fulfilled the inclusion criteria.
They were given written and oral information and were
referred for baseline examinations (Fig. 1). Informed writ-
ten consent was obtained from all participants before the
baseline examination. After completing baseline examina-
tions, the participants were randomized and informed of
group allocation. An appointment for an individual intro-
ductory meeting with the specific physiotherapist guiding
each intervention was scheduled with each participant.
The study was approved for all sites by the Regional ethics
committee in Stockholm (2010/1121-31/3).
Randomization
Randomization was conducted separately for each site in
blocks of six subjects by a computer generated sequence
[33]. For each participant the treatment was concealed
in sequentially numbered, sealed, opaque envelopes.
Randomization and concealment was done by a person
not involved in the examinations or treatments (ME).
When a participant had been included the envelope was
opened together with each participant, after which she
was informed about the group to which she had been
allocated.
Intervention
Rationale for the resistance exercise program: the main
goal was to improve muscle strength and health status
by progressive resistance exercise, but without risking
increased pain while loading the muscles. It was unclear
how many participants would be able to manage exercise
at higher loads. Exercise of large muscle groups, prefera-
bly muscles in the lower extremities were chosen, as riskof activity-induced pain was anticipated to be higher when
loading muscles of upper extremities. Exercises improving
core stability and power were included in the program.
Person-centered intervention: the resistance exercise
program was performed twice a week for 15 weeks and
was supervised by experienced physiotherapists. It was
conducted at physiotherapy premises and at a local gym
at four different sites in groups comprising five to seven
participants to promote interaction between participants
and to facilitate physiotherapeutic guidance. The interven-
tion was preceded by an individual introductory meeting.
The meeting was commenced with a dialogue between
the participant and the physiotherapist about the partici-
pant’s earlier experiences and thoughts of exercise, which
could potentially be an obstacle for her ability to exercise
despite her explicit intention to do so. The introductory
meeting also included exercise instructions, testing and
adjustment of loads and modifications of specific exercises
according to individual conditions and according to self-
efficacy principles [34] of each participant’s confidence in
their ability to perform each exercise and to manage spe-
cific loads. The meeting resulted in a written protocol with
descriptions of specific exercises and loads, which was
used by each participant as an exercise program at each
exercise session. To promote the participant’s sense of
control, and to avoid possible negative effects related to
exercise, the exercise was initiated at low loads, and possi-
bilities for progressions of loads were evaluated every 3−4
weeks in dialogue between the physiotherapist and partici-
pant (Box 1). When the participant was not ready to in-
crease exercise loads, she continued exercising on the
same loads until she was ready to do so. This mode of ex-
ercise was anticipated to increase exercise self-efficacy, en-
hance the ability to choose the proper level of exercise
and better manage symptoms.
Estimation of one repetition maximum (1RM) was
made by submaximal ratings of perceived exertion for
health and safety reasons [35]. The participants were
asked to perform their maximum number of repetitions
until perceived exhaustion at an individually adjusted,
given resistance. 1RM was based on the number of repe-
titions performed.
Active control group: the relaxation therapy was
performed twice a week for 15 weeks and was guided
by experienced physiotherapists. It was conducted at
physiotherapy premises at four different sites in groups
comprising five to eight participants and was preceded
by an individual introductory meeting at the premises,
which included instructions and allowed for prepara-
tions and modifications of practical matter such as
positioning and the use of mattresses and pillows to
reach a good level of comfort. The relaxation therapy
was performed as autogenic training [31], which refers
to a series of mental exercises including relaxation and
Fig. 1 Consolidated Standards of Reporting Trials (CONSORT) flow diagram of the progress of the two groups of the randomized trial. FM fibromyalgia
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pants through their bodies, during approximately 25
minutes, by focusing their minds on the bodily experi-
ence of relaxation and letting the body part in focus
rest on the ground. This was repeated for each specific
body-part, aiming at feeling as relaxed as possible in
the whole of the body at the end of the session. After each
session the participants were invited to share experiences
and ask each other and the physiotherapist questions, and
continued thereafter with the stretching exercises.
Assessment
Outcomes were assessed at baseline and at post-treatment
examination after 15 weeks. Follow up was conducted
13–18 months after the baseline and only included self-
reported questionnaires. All participants were invited to a
post-treatment examination according to an intention-to-
treat design. Baseline examinations and examinations after
15 weeks of intervention included serum samples for later
analysis (not analyzed in this study), self-reported ques-
tionnaires, performance-based tests of muscle strength
and physical capacity and assessment of current pain
intensity. Background data were gathered using a stan-
dardized interview and included age, symptom duration,
tender points, body mass index (BMI), level of leisure time
physical activity (LTPAI) [36], pharmacological treatment,
education, family status, country of birth, work status, and
sick leave (Table 1). Examinations were conducted at
physiotherapy premises by physiotherapists who were
blinded to group allocation. Baseline and post-treatment
examinations were performed by the same physiothera-
pists. The 13–18 month follow up comprised self-reported
questionnaires only and was sent to the participants by
mail. The participants who did not return the question-
naires in a reasonable time were reminded by telephone.
After three reminders, participants that had not returned
their questionnaires were regarded as missing. The partici-
pants that were already lost at post-treatment examina-
tions were regarded as missing and were not contacted for
follow up at 13–18 months.
Outcomes
Resistance exercise was the core element of the inter-
vention, but the program also involved other interacting
components, such as the partnership between the physio-
therapist and the participant when planning and progres-
sing the exercise program. It was anticipated that both the
voluntary activity of the participant and the severity of her
health problems would influence the outcomes of the
intervention. The prevalent evidence of the benefits of re-
sistance exercise in FM is of low quality [15], and there-
fore muscle strength was selected as the primary outcome.
Pain intensity, physical capacity, health status and other
variables associated with health problems in chronic painwere selected for secondary outcomes, as exercising was
also thought to impact on these variables.
The primary outcome was isometric knee-extension
force (N) measured with a dynamometer (Steve Strong®:
Stig Starke HBI, Göteborg, Sweden) using a standard
protocol. The participant was in a fixed seated position
with back support, knee and hip in 90 ° of flexion and
legs hanging freely. A non-elastic strap was placed around
the ankle and attached to a pressure transducer with an
amplifier. The subjects were instructed and verbally en-
couraged to pull the ankle strap with maximal force for 5
seconds. Three trials were performed for each test and
there was a one minute rest between each trial. The best
performance out of three trials was recorded. A mean
value from the right and left leg was calculated. The in-
strument has been used in previous studies of physical
performance [37, 38] and has been reported to show satis-
factory test-retest reliability for patients with a chronic
condition [37].
Secondary outcomes were: the fibromyalgia impact
questionnaire (FIQ) is a disease-specific self-reported ques-
tionnaire that comprises ten subscales of disabilities and
symptoms ranging from 0 to 100. The total score is the
mean of ten subscales. A higher score indicates a lower
health status [39]. This instrument has shown good sensi-
tivity in demonstrating therapeutic change [40]; current
pain intensity (VAS), rated on a plastic 0-100 visual
analogue scale with a moveable cursor along a line and
anchors at the extremes. The participant was asked to
rate her current pain intensity ranging from no pain at all
to the worst imaginable pain; the six-minute walk test
(6MWT), a performance-based test that measures total
walking distance (m) during a period of 6 minutes [41];
maximal isometric elbow flexion force (kg) in both arms,
was measured one by one using a dynamometer (Isobex®:
Medical Device Solutions AG, Oberburg, Switzerland).
The participant was in a seated position without back
support, with the legs stretched out in front. The upper
arm was aligned with the trunk and the elbow was placed
in 90° of flexion. The maximum strength obtained during
a period of 5 seconds was recorded and used in the
present study [42]. Three trials were performed for each
test and there was a one minute rest between each trial.
The best performance out of three trials was recorded. A
mean value from the right and left arm was calculated;
hand grip force (N) bilaterally registered using Grippit®
(AB Detektor, Göteborg, Sweden). The mean force over a
set period of time (10 seconds) was recorded [43]. Two
trials were performed for each test and there was a one
minute rest between each trial. The best performance out
of two trials was recorded. A mean value of the right and
left hand was calculated and used in the present study;
Short Form Health Survey (SF-36), a generic instrument
assessing health related quality of life [44]. A higher score





(n = 67) (n = 63)






Age, years 50.81 (9.05) 52.10 (9.78) 0.27
51 (25; 64) 55 (22; 64)
Symptom duration,
years
11.06 (8.53) 9.44 (7.33) 0.38
9 (0; 35) 8 (0; 30)
Tender points,
number
15.76 (1.92) 15.49 (2.00) 0.48
16 (11; 18) 16 (11; 18)
Body mass index 27.39 (5.29) 28.66 (5.32) 0.06
26 (20; 41) 27 (18; 43)
LTPAI, h 5.62 (4.80) 5.79 (6.25) 0.52
4 (0; 28) 4 (1; 38)
Number (%) Number (%)
Pharmacologigal treatment
NSAID paracetamol
Yes 53 (79 %) 44 (70 %) 0.22
Opioids for mild to
moderate pain
Yes 13 (19 %) 12 (19 %) 1.00
Antidepressants
Yes 32 (48 %) 24 (38 %) 0.22
Anticonvulsives
Yes 4 (6 %) 2 (3 %) 0.68
Sedatives
Yes 11 (16 %) 12 (19 %) 0.82
Education
≤9 years 8 (12 %) 15 (24 %)
10–12 years 34 (51 %) 22 (35 %)
>12 years 25 (37 %) 26 (41 %) 0.88
Living with an adult
Yes 45 (67 %) 40 (64 %) 0.71
Born in Sweden 60 (90 %) 56 (89 %) 0.56
Work status
0 % 29 (43 %) 26 (41 %)
20–49 % 2 (3 %) 4 (6 %)
50 % 13 (19 %) 11 (18 %)
51–79 % 8 (12 %) 8 (13 %)
100 % 15 (22 %) 14 (22 %) 0.71
Sick leave/disability pension
25 % 9 (13 %) 5 (8 %)
Table 1 Characteristics of the study population (Continued)
50 % 16 (24 %) 9 (14 %)
75 % 2 (3 %) 3 (5 %)
100 % 21 (31 %) 22 (35 %) 0.86
Missing values, LTPAI: n = 1. NSAID non-steroidal anti-inflammatory drugs,
LTPAI leisure time physical activity instrument
Larsson et al. Arthritis Research & Therapy  (2015) 17:161 Page 6 of 15indicates better health. The subscales that build two com-
posite scores, the physical component scale (PCS) and the
mental component scale (MCS), were used in this study;
the pain disability index (PDI), an instrument for measur-
ing the impact that pain has on the ability of a person to
participate in essential life activities on a scale from 0 to
70. The higher the index is, the greater the person’s dis-
ability due to pain [45, 46]; the chronic pain acceptance
questionnaire (CPAQ), which assesses the degree of pain-
related acceptance. It consists of 20 items ranging from 0
(never true) to 6 (always true). A higher score indicates a
higher level of acceptance. The total score (0–120) is pre-
sented in this study [47]; the fear avoidance beliefs ques-
tionnaire (FABQ), a questionnaire with two sub-scales
that assess the extent to which fear and avoidance affect
work beliefs (7 items range 0–42) and physical beliefs (4
items 0–24) in patients with chronic pain. A higher score
represents greater fear avoidance beliefs [48]; and the pa-
tient global impression of change (PGIC), a numeric scale
ranging from 1 (very much improved) to 7 (very much
worse), where a lower score indicates greater improve-
ment. This instrument assesses perceived global impres-
sion of change from the patient’s perspective [49]. The
PGIC was measured at post-treatment examinations and
at 13–18 month follow up.Statistical analysis
Data were computerized and analyzed using the Statis-
tical Package Software for the Social Sciences (SPSS
version 22.0, Chicago, IL, USA). Descriptive data are
presented as mean, SD, median (min; max) for continu-
ous variables or the number (n) and percentage (%) for
categorical variables. For comparison between two groups,
the Mann-Whitney U test was used for continuous
variables, Fisher’s exact test was used for dichotomous
variables, and the Mantel Haenzel test was used for or-
dinal categorical variables. The Wilcoxon signed rank test
was used for comparison between baseline and post-test
within groups for continuous variables. Spearman correl-
ation analysis was used for analyzing correlations between
the PGIC and outcomes. To control possible type I er-
rors, the upper limit of the expected number of false sig-
nificant results for the analyses was calculated by the
following formula:
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where α is the significance level. All significance tests
were two-sided and conducted at the 5 % significance
level. Outcomes were analyzed according to the intention-
to-treat design, implying that all participants were invited
to post-treatment examination, whether they had partici-
pated in the intervention or not. Only measured values
were included in analyses of changes over time between
the two groups and within the groups implying that cases
missing were not included in the analysis. Effect size was
calculated for variables showing a significant change. Ef-
fect size for between-group analyses was calculated by
dividing the mean difference between the post-treatment
score and baseline score in the intervention group and in
the control group by the pooled SD for difference. Effect
sizes from 0.20 to <0.50 were regarded as small, while ef-
fect sizes from 0.50 to <0.80 were regarded as moderate
[50]. No previous data were found for isometric knee-
extension force in FM using the selected dynamometer
(the primary outcome), but the same methodology was
applied in a study of women with chronic disease. Their
isometric knee-extension force was 263 N, SD 100 [37].
Based on that report, 59 participants per group would be
satisfactory to detect a 20 % difference with 80 % power
when the significance level was set to 5 %.
Results
Participants
There were no significant baseline differences between
the resistance exercise group (n = 67) and the active
control group (n = 63) in background data (Table 1), or
the primary outcome or secondary outcomes.
Intention-to-treat analysis
All participants were invited to a post-treatment examin-
ation according to the intent-to-treat design and 81 % of
the total sample completed the test, 56 (84 %) belonging
to the resistance exercise group and 49 (76 %) in the ac-
tive control group (Fig. 1). A total of 17 participants (25
%) in the resistance exercise group, and 20 (32 %) in the
active control group discontinued the intervention for
various reasons (Fig. 1). No significant differences were
found when comparing the baseline characteristics of
the women who completed and the women who failed
to complete the post-treatment examinations. Adverse
effects were reported by five participants, all in the re-
sistance exercise group, who chose to discontinue the
intervention due to increased pain (Fig. 1), but two of
these participants completed post-treatment examina-
tions. Mean attendance rate at the resistance exercise
sessions was 71 % and 64 % at the relaxation therapy
sessions (range 0 to 100 % in both groups).Exercise loads
A total of 42 participants (62.7 %) in the resistance exer-
cise group reached exercise loads of 80 % of 1RM while
7 participants (10.4 %) reached exercise loads of 60 % of
1RM. The women in the resistance exercise group who
managed to reach exercise loads of 80 % of 1RM (n =
42, 63 %) showed significantly better physical capacity
represented by 6MWT (p = 0.040) and health status rep-
resented by FIQ total score (p = 0.029) at baseline than
the women in the resistance exercise group who did not
reach exercise levels of 80 % of 1RM (Table 2).
Type I error: the between-group analyses comprised a
total of 12 statistical analyses, with 7 significant values at
the significance level 0.05, and the upper level of the
number of false significant results was 0.26, which indi-
cates that 0–1 of the significant results observed might
be false.
Primary outcome
Significantly greater improvement (p = 0.010) was found
for isometric knee-extension force in favor of the resist-
ance exercise group as compared to the active control
group (Table 3). The effect size of change in isometric
knee-extension force for the intervention group compared
with the active control group was 0.55 (i.e., a moderate ef-
fect size). A total of 30 % of the participants fulfilling the
resistance exercise program (n = 49) improved their iso-
metric knee-extension force by 20 % or more, while the
changes ranged from 51 % to 126 % on the individual
level, implying large variation among the participants.
No significant baseline differences (p = 0.51) were
found for isometric knee-extension force between the
three sites. Mean difference for change in isometric knee-
extension force from baseline to post-treatment examina-
tions between the two groups was 43.0 N (standard error
(SE) 22.5), 40.1 N (SE 24.6), and 35.2 N (SE 23.1) at each
site respectively.
Secondary outcomes
Significantly greater improvement was observed in health
status (FIQ total score) (p = 0.038) in the resistance exer-
cise group compared to the active control group (Table 3).
The effect size of the change in the FIQ total score for the
intervention group compared with the active control
group was 0.41. Significantly greater improvement was ob-
served in current pain intensity (VAS) (p = 0.033) in the
resistance exercise group compared to the active control
group (Table 3). The effect size of the change in current
pain intensity for the intervention group compared with
the active control group was 0.46. Significantly greater im-
provement was observed in the 6MWT (p = 0.003) in the
resistance exercise group compared to the active control
group (Table 3). The effect size of the change in the
6MWT for the intervention group compared with the
Table 2 Comparison of baseline values for participants in the resistance exercise group who reached exercise loads of 80 % and
participants in the resistance exercise group who reached exercise loads up to 60 %
Resistance exercise (experimental)
Baseline values of participants
reaching loads of 80 %
Baseline values of participants
reaching loads ≤60 %
Comparison of baseline
values between groups
(n = 42) (n = 25)
Measures Mean (SD) Mean (SD) P value
Median (min; max) Median (min; max)
Age, years 50.26 (9.65) 51.7 (8.1) 0.68
51 (25; 64) 52 (33; 63)
Symptom duration, years 11.44 (8.31) 10.4 (9.0) 0.47
10 (0; 35) 8 (0; 30)
Tender point count, number 15.57 (1.92) 16.08 (1.91) 0.30
16 (11; 18) 17 (12; 18)
Body mass index 26.75 (4.2) 28.5 (6.7) 0.48
26 (21; 36) 27 (20; 41)
LTPAI, h 4.87 (3.87) 6.9 (5.9) 0.17
4 (0;18) 6 (1;28)
Primary outcome
Isometric knee-extension force, N 347.3 (106.2) 301.2 (110.7) 0.11
344 (114;643) 305 (111;585)
Secondary outcomes
FIQ total score (0-100) 57.3 (12.7) 65.9 (15.8) 0.029
55.2 (31; 81) 64 (40; 95)
Current pain intensity, visual analog scale 49.5 (22.1) 48.8 (27.19) 0.68
54 (12; 89) 50 (5;100)
6MWT, m 573.7 (70.3) 527.7 (75.5) 0.040
570 (376; 766) 548 (360; 655)
Isometric elbow-flexion force, kg 13.1 (5.3) 12.9 (5.7) 0.76
13 (2; 26) 13 (3; 32)
Isometric hand-grip force, N 168.4 (70.4) 150.7 (65.6) 0.30
162 (34; 319) 169 (62; 315)
SF36 PCS, 0–100 31.7 (7.5) 30.3 (8.8) 0.32
31 (12; 49) 30 (18; 49)
SF36 MCS, 0–100 39.8 (11.9) 34.0 (12.1) 0.10
41 (10; 59) 35 (13; 61)
PDI, 0–70 34.3 (11.6) 36.9 (13.4) 0.40
34 (12; 69) 39 (8; 62)
CPAQ total, 0–120 66.0 (14.5) 59.5 (18.0) 0.13
64 (35; 99) 59 (19; 106)
FABQphysical, 0–24 9.0 (5.9) 12.6 (7.1) 0.23
9 (0; 23) 13 (2; 24)
FABQwork, 0–42 16.1 (12.3) 20.0 (13.9) 0.37
14 (0; 42) 21 (0; 39)
6MWT 6 minute walk test, SF36 PCS Short Form 36 physical component scale, SF36 MCS Short Form 36 mental component scale, CPAQ chronic pain acceptance
questionnaire, PDI pain disability index, FABQ fear avoidance beliefs questionnaire
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Table 3 Between-group analysis and within-group analysis of the primary and secondary outcomes
Measures Resistance exercise (experimental) Relaxation therapy (control) Between-group
analysis
of change
Baseline Post test Post-test- baseline Within-group
analysis
Baseline Post test Post-test- baseline Within-group
analysis(n = 67) (n = 56) (n = 56) (n = 63) (n = 49) (n = 49)
Mean (SD) Mean (SD) Δ (SD) p value Mean (SD) Mean (SD) Δ (SD) p value p value




330.1 (109.4) 356.2 (118.9) 30.4 (71.9) 0.002 298.8 (107.8) 276.4 (112.9) −8.8 (70.0) 0.644 0.010
326 (111; 643) 342 (105; 663) 31 (−157; 178) 287 (51; 534) 278 (41; 595) −10 (−222; 132)
Secondary outcomes
FIQ total, 0–100 60.5 (14.4) 54.4 (18.2) −5.7 (15.0) 0.009 61.1 (17.3) 59.3 (16.0) 0.1 (12.9) 0.71 0.038
59 (31; 95) 55 (11; 88) −3 (−51; 20) 61 (17; 88) 61 (21; 86) 1 (−34; 25)
Current pain intensity, VAS 49.3 (23.9) 38.6 (25.2) −11.5 (25.1) 0.002 52.4 (18.3) 53.4 (20.0) −1.5 (16.5) 0.63 0.033
50 (5; 100) 31 (0; 95) −13 (−83; 48) 51 (10; 88) 56 (10; 86) −2 (−51; 30)
6MWT, m 556.6 (75.1) 579.7 (73.7) 18.4 (65.1) 0.002 540.7 (64.5) 533.9 (73.1) −5.6 (43.5) 0.51 0.003
566 (360; 766) 582 (340; 762) 24 (−290; 196) 530 (362; 660) 537 (366; 656) 1 (−125; 101)
Isometric elbow flexion
force, kg
13.0 (5.4) 14.8 (5.6) 2.4 (3.3) <0.001 10.9 (5.2) 11.7 (5.6) 1.2 (3.3) 0.020 0.020
13 (2; 32) 15 (2; 27) 2 (−5; 12) 10 (2; 24) 12 (3; 27) 1 (−7; 13)
Hand-grip force, N 161.8 (68.7) 181.1 (61.5) 20.1 (36.1) <0.001 139.4 (61.7) 147.2 (66.7) 14.0 (37.9) 0.013 0.49
164 (34; 319) 185 (38; 327) 14 (−32; 158) 134 (40; 311) 146 (39; 327) 9 (−101; 98)
SF36 PCS, 0–100 31.2 (7.9) 34.5 (9.1) 3.3 (7.2) 0.004 29.9 (8.1) 30.7 (8.3) 0.8 (5.7) 0.28 0.11
31 (12; 50) 35 (14; 54) 3 (−13; 18) 30 (10; 50) 30 (17; 47) 1 (−13; 13)
SF36 MCS, 0–100 37.7 (12.2) 42.0 (12.6) 3.3 (10.3) 0.007 39.6 (12.1) 38.8 (12.9) −0.4 (9.5) 0.86 0.054
37 (10; 61) 44 (12; 62) 3 (−23; 35) 42 (16; 59) 41 (13; 61) 0 (−22; 23)
PDI, 0–70 35.3 (12.2) 32.2 (13.1) −3.8 (10.6) 0.006 35.0 (12.5) 35.7 (12.4) 1.4 (9.0) 0.27 0.005
36 (8; 69) 34 (7; 67) −5 (−29; 23) 34 (7; 61) 38 (9; 58) 0 (−19; 21)
CPAQ, 0–120 63.6 (16.1) 69.6 (15.2) 5.7 (13.1) 0.002 62.4 (17.1) 63.4 (19.1) 0.1 (11.8) 0.79 0.043
63 (19; 106) 69 (34; 98) 6 (−27; 46) 61 (15; 107) 60 (30; 113) 2 (−38; 23)
FABQphysical, 0–24 9.7 (6.1) 8.9 (6.1) −0.8 (7.0) 0.36 11.2 (6.1) 10.3 (6.3) −1.3 (5.6) 0.24 0.92
9 (0; 24) 8 (0; 22) −1 (−19;19) 11 (0; 24) 9 (0; 24) 0 (−18;10)
FABQwork, 0–42 17.2 (12.7) 17.8 (13.1) 0.4 (8.9) 0.83 15.9 (12.1) 16.67 (12.5) 1.2 (8.1) 0.54 0.79
16 (0; 42) 16 (0; 42) 0 (−27; 29) 12 (0; 42) 14 (0; 42) 0 (−19; 30)
Missing values at baseline: Resistance exercise group, SF36 PCS and SF36 MCS, n = 1; FABQwork, n = 6, FABQphysical, n = 1; Relaxation therapy group, CPAQ, n = 1; FABQwork, n = 8. Missing post-test values: Resistance
exercise group, SF36 MCS and PCS, n = 3; FABQwork, n = 7; FABQphysical, n = 2; Relaxation therapy group, FIQtotal, n = 1; SF36 PCS and MCS, n = 2; FABQwork, n = 9. Significant p values are shown in bold text. 6MWT
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provement was observed in isometric elbow-flexion force
(p = 0.020) in the resistance exercise group compared with
the active control group (Table 3). The effect size of the
change in isometric elbow flexion force for the interven-
tion group compared with the active control group was
0.36. There was no significant difference between groups
in hand-grip force; both the exercise intervention group
and the active control group improved their strength sig-
nificantly (p <0.001, p = 0.013) (Table 3).
Significant improvements were observed in the health
related quality of life (SF-36 PCS and MCS) (p = 0.007)
within the resistance exercise group, reflecting what is
considered to be a clinically important difference [51].
No significant differences were found when comparing
the resistance exercise group with the active control group
(Table 3). Significantly greater improvement in pain dis-
ability represented by the PDI (p = 0.005) was observed in
the resistance exercise group compared to the active con-
trol group (Table 3). The effect size of the change in the
PDI for the intervention group compared with the active
control group was 0.53. Significantly greater improvement
in pain acceptance represented by the CPAQ (p = 0.043)
was observed in the resistance exercise group as compared
to the active control group (Table 3). The effect size of the
change in the CPAQ for the intervention group compared
with the active control group was 0.45. No differences
within groups or between groups were found for fear
avoidance beliefs represented by the FABQ (Table 3).
PGIC
PGIC differed significantly (p = 0.001) in favor of the re-
sistance exercise group as compared with the active con-
trol group at post-treatment examinations. A total of 62.5
% of the participants in the resistance exercise group and
32.7 % in the active control group reported improvement
in symptoms. PGIC ratings correlated significantly with
improvements in current pain intensity (VAS) (rs 0.38, p =
0.004) and SF-36 PCS (rs 0.54, p <0.001) in the resistance
exercise group.
There were no significant differences in the level of
leisure time physical activity (LTPAI) (p = 0.74) between
the resistance exercise group (5.6 h, SD 5.1) and the ac-
tive control group (5.9 h, SD 5.2) at baseline. The level
of moderate to vigorous physical activity at baseline in
the resistance exercise group was 2.4 h (SD 2.6) and in
the active control group 2.2 h (SD 2.1) (p = 0.89). Dur-
ing the intervention period, the level of physical activity
increased significantly (p <0.001) in the resistance exer-
cise group (2.3 h, SD 4.8) compared to the active control
group (−0.1 h, SD 4.8). Moderate to vigorous physical ac-
tivity increased significantly more (p = 0.003) in the resist-
ance exercise group (1.8 h, SD 3.0) compared to the active
control group (0.4 h, SD 2.6).Follow up at 13–18 months
A total of 91 (70 %) participants completed the follow
up, 48 (72 %) in the resistance exercise group and 43 (68
%) in the active control group, respectively (Fig. 1). No
significant differences between the resistance exercise
group and the active control group were found at follow
up after 13–18 months when compared to baseline
measures of these outcomes (Table 4). The only signifi-
cant within-group improvement at follow up in the re-
sistance exercise group was for pain acceptance (CPAQ)
(p = 0.044) (Table 4).
There was no significant difference (p = 0.07) in the
level of leisure time physical activity (LTPAI) from base-
line to follow up between the resistance exercise group
(−0.4, SD 4.9) and the active control group (−1.4, SD
2.6), as both groups had slightly decreased their total
physical activity. However, at the same time, both groups
had increased the level of moderate to vigorous physical
activity (p = 0.74), represented by 0.8 h (SD 4.5) in the
resistance exercise group and 0.9 h (SD 3.1) in the active
control group.
Discussion
The main findings of this study were significant improve-
ments in isometric knee-extension force, current pain
intensity, and other aspects of health in the resistance ex-
ercise group compared to the active control group. These
results were supported by significant within-group im-
provements in the resistance exercise group. The im-
provement of the knee-extension force is in line with a
previous study of resistance exercise in women with FM
[21]. The effect size of change in the isometric knee-
extension force indicated a moderate improvement in the
resistance exercise group as compared with the control
group. The mean improvement in isometric knee-
extension force was smaller in our sample than in the
two previous studies [21, 52], and one reason for this
might be the longer intervention period of these studies
which was 21 weeks compared to 15 weeks in our study
[21, 52]. Other reasons for the difference in improve-
ment may be related to differences in the measurement
equipment, population characteristics, disease severity
and exercise parameters. The significant between-group
differences found in elbow-flexion force in favor of the
resistance exercise group were supported by significant
within-group improvements in the resistance exercise
group. To our knowledge this is the first resistance exer-
cise study showing that women with FM can improve
their biceps strength by resistance exercise. Elbow-
flexion force and hand-grip force had also improved
significantly in the active control group. A reason for
the improvement might be reduced tension in upper-
extremity muscles. A previous study showed that pa-
tients with FM displayed higher levels of unnecessary
Table 4 Between-group analysis and within-group analysis of outcomes assessed at follow up after 13–18 months











(n = 67) (n = 48) (n = 48) (n = 63) (n = 43) (n = 43)
Mean (SD) Mean (SD) Δ (SD) p value Mean (SD) Mean (SD) Δ (SD) p value p value
Median (min; max) Median (min; max) Δ (min; max) Median (min; max) Median (min; max) Δ (min; max)
Secondary outcomes
FIQ total, 0–100 60.5 (14.4) 57.1 (19.4) −1.8 (17.0) 0.71 61.1 (17.3) 55.4 (17.0) −3.4 (12.3) 0.065 0.35
59 (31; 95) 59 (17; 92) 1 (−45; 35) 61 (17; 88) 55 (15; 90) −3 (−28; 36)
Current pain intensity, VAS 49.3 (23.9) 49.2 (20.8) 0.7 (23.4) 0.87 52.4 (18.3) 52.1 (19.5) −2.9 (19.6) 0.45 0.52
50 (5; 100) 47 (9; 84) 3 (−73; 58) 51 (10; 88) 53 (5; 83) −2 (−62; 46)
SF36 PCS, 0–100 31.2 (7.9) 32.2 (8.0) 0.8 (7.1) 0.39 29.9 (8.1) 32.0 (9.4) 1.9 (7.3) 0.16 0.62
31 (12; 50) 30 (17; 54) 1 (−14; 14) 30 (10; 49) 32 (17; 52) 1 (−13; 19)
SF36 MCS, 0–100 37.7 (12.2) 39.2 (13.9) −0.4 (13.5) 0.78 39.6 (12.1) 40.0 (11.9) −0.4 (12.2) 0.66 0.89
37 (10; 61) 39 (10; 59) 0 (−28; 29) 42 (16; 59) 43 (19; 60) −2 (−23; 28)
PDI, 0–70 35.3 (12.2) 33.0 (11.6) −2.6 (9.7) 0.094 35.0 (12.5) 33.7 (10.9) −0.3 (10.1) 0.58 0.42
36 (8; 69) 34 (7; 62) −3 (−28; 17) 34 (7; 61) 35 (8; 54) −1 (−21; 25)
CPAQ total, 0–120 63.6 (16.1) 68.0 (15.4) 3.6 (11.3) 0.044 62.4 (17.1) 66.6 (17.1) 2.3 (14.0) 0.21 0.76
63 (19; 106) 70 (33; 100) 3 (−21; 32) 61 (15; 107) 63 (24; 101) 1 (−35; 28)
FABQphysical, 0–24 9.7 (6.1) 10.1 (5.2) −0.1 (5.5) 0.57 11.2 (6.1) 9.7 (6.3) −1.6 (4.5) 0.051 0.38
9 (0; 24) 10 (2; 21) 0 (−10; 17) 11 (0; 24) 10 (0; 24) −1 (−14; 5)
FABQwork, 0–42 17.2 (12.7) 15.5 (11.5) −1.8 (9.7) 0.20 15.9 (12.1) 14.7 (12.4) −1.0 (11.2) 0.66 0.59
16 (0; 42) 14 (0; 41) −1 (−30; 32) 12 (0; 42) 13 (0; 42) 0 (−41; 30)
Missing values at baseline: Resistance exercise group, SF36 PCS and SF36 MCS, n = 1; FABQwork, n = 6; FABQphysical, n = 1. Relaxation therapy group, CPAQ, n = 1; FABQwork, n = 8. Missing values at 13–18 month follow
up, Resistance exercise group, current pain intensity, n = 2; FABQwork, n = 5; SF36 PCS and SF36 MCS, n = 1. Relaxation therapy group, FABQwork, n = 7; FABQphysical, n = 1; SF36 PCS and SF36 MCS, n = 1. Significant
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during dynamic activities compared to pain-free controls
[53]. Our interpretation is that the relaxation therapy re-
sulted in lower tension in the shoulder muscles and thus
increased the hand-grip force. Also, walking capacity,
measured with 6MWT improved with resistance exercise
which is in line with previous reports of resistance exer-
cise in women with FM [54].
The mean improvement in current pain intensity in
the resistance exercise group represented an improve-
ment of 23 %, which is considered a clinically important
difference, as a reduction of 15 % represents a minimal
clinically important difference [55]. The improvements
in pain intensity are in line with reports from previous
studies of improvements in pain following resistance ex-
ercise in FM [21, 54, 56, 57]. Also, the improvements in
FIQ total score support previous findings in studies of
women with FM engaging in resistance exercise [56, 57].
PGIC differed significantly in favor of the resistance
exercise group. We found that PGIC correlated with im-
provements in current pain intensity and SF-36 physical
component score, which implies that the participants’
overall impressions of change reflect clinically important
improvements in disease-related health problems. These
findings are in line with a previous report on FM from
OMERACT [58]. Notable is that the improvements in
SF36 scores in the resistance exercise group can be
regarded as clinically important differences [51]. Signifi-
cantly improved pain disability (assessed by the PDI) with
a moderate effect-size for change indicated improvement
in participation in everyday life activities, which reflects
that the intervention focusing on enhancement in self-
confidence and pain management during the exercise
sessions was successful. Further, significantly improved
pain acceptance (assessed by the CPAQ), was found in the
resistance exercise group compared with the active con-
trol group. Acceptance of pain is assumed to be associated
with less disability and better functioning in patients
with chronic pain [47], and the results of this study indi-
cate that pain acceptance can be improved when en-
gaging in exercise.
The mean attendance rate was 71 % at the resistance
exercise sessions and 64 % at the relaxation therapy ses-
sions, which is regarded as a satisfactory rate in patients
with severe health problems. The progression of the
resistance exercise program proved to be a successful
mode of exercise for most participants, as the majority
tolerated the exercise well and few participants experi-
enced aggravated symptoms.
Pain acceptance (CPAQ) was the only significant im-
provement found at follow up after 13–18 months in the
resistance exercise group, which implies that the interven-
tion promoted a process of pain acceptance that has long-
term effects. However this finding should be interpretedwith caution due to the fact that multiple comparisons
were conducted. A probable reason for the lack of other
long-term effects is that physical activity levels declined to
baseline levels after the end of the intervention period.
This implies that the participants had difficulties with
maintaining regular resistance exercise without supervi-
sion. Some of the reasons given by participants for not
continuing exercising were expensive gym membership,
need for continued supervision and guidance, and difficul-
ties in prioritizing exercise in daily life. A similar lack of
long-lasting effects and difficulties among women with
FM to maintain their levels of resistance exercise after the
end of intervention have previously been reported [57]. A
longer period of guidance and support might increase the
prospects for long-lasting effects [59].
In this study, 81 % of the study population completed
post-treatment examination, indicating satisfactory com-
pliance. Five participants (7 %) in the resistance exercise
group reported adverse effects and three of these did not
complete the post-treatment examination. Adverse ef-
fects in this study are in line with a previous study of re-
sistance exercise in women with FM [56]. In this study,
63 % of the participants managed to attain exercise loads
of 80 % of 1RM. At baseline, these participants pre-
sented with better physical capacity in terms of 6MWT,
and health status in terms of FIQ total score than those
who did not reach loads of 80 %, implying that personal
instructions and progression of exercise loads need to be
adjusted to the participants’ physical resources and
health status.
Muscle-strengthening activity, such as resistance exer-
cise, at least twice a week is recommended for prevent-
ing age-related loss of muscle mass, impaired physical
function [60] and the development of degenerative age-
related chronic conditions [61] in older adults in the gen-
eral population. The prevention of loss of muscle mass
and physical function due to aging could be argued as
even more important in this population given the im-
paired muscle strength [8, 9] and reduced levels of phys-
ical activity [22] previously shown in women with FM.
Further, the benefits of regular progressive resistance exer-
cise on muscle strength, pain, health status and participa-
tion in daily life activities shown in this study implies that
resistance exercise can be recommended as a safe and ef-
fective option for exercise, which warrants inclusion in the
management of FM.
Implications
The positive results of the study showed that a supervised
resistance exercise program based on person-centered
principles with individually adjusted loads and progression
according to each participant’s resources is feasible and
successful. This program can be recommended to the gen-
eral population of women with FM as the characteristics
Larsson et al. Arthritis Research & Therapy  (2015) 17:161 Page 13 of 15of our study sample in terms of tender points, pain inten-
sity levels and FIQ scores appear to be representative of
women with FM in general [54, 56, 62]. However, strat-
egies to support long-term regular exercise should be de-
veloped to ensure longstanding health effects.Limitations
The recruitment procedure i.e., newspaper advertisement
may have resulted in recruitment of participants who were
motivated to exercise and this could bias the results. To
minimize this risk the advert was designed to recruit par-
ticipants to both interventions so none of the participants
would know in advance which intervention was the active
intervention or the control intervention. Unlike pharma-
cological studies, which are easily blinded, behavioral and
physical treatment requiring the active participation of pa-
tients is virtually impossible to blind or make inert.Conclusion
Person-centered progressive resistance exercise was shown
to be a feasible mode of exercise for women with FM, im-
proving muscle function, health status, current pain inten-
sity, pain management and participation in activities of
daily life. At long-term follow up the effects had declined
to baseline levels, implying that a longer period of guidance
and support is recommended to increase the possibilities
of maintaining regular exercise habits.Box 1 Dosage of resistance exercise, individualized
according to each participant’s resources
Frequency: 2 times per week for 15 weeks, supervised by
physiotherapists
Exercise sessions: 10 minute warm up, 50 minute standardized
protocol including: leg-press, knee-extension and knee-flexion
using weight machine, biceps curl and hand grip strength using
free weights, heel raise and core stability using body weight
and 10 minutes of stretching exercises. Exercises for explosive
strength were added to the protocol five weeks, and eight
weeks into the intervention with rapid heel-raises and explosive
knee-extensions respectively.
Progression: baseline: 40 % of 1 RM, with 15–20 repetitions in
1–2 sets. Three to four weeks: 60 % of 1 RM, with 10–12
repetitions in 1–2 sets. 6–8 weeks: 80 % of 1RM, performed with
5–8 repetitions in 1–2 sets.
Between each set there was a 1 minute recovery.Abbreviations
1RM: one repetition maximum; 6MWT: six minute walk test; ACR: American
College of Rheumatology; BMI: body mass index; CPAQ: chronic pain
acceptance questionnaire; FIQ: fibromyalgia Impact Questionnaire;
FM: fibromyalgia; LTPAI: leisure time physical activity; NSAID: non-steroidalanti-inflammatory drugs; PGIC: patient global impression of change;
SE: standard error; SF36: Short Form 36; SF36-MCS: Short Form 36-mental
component scale; SF36-PCS: Short Form 36-physical component scale;
VAS: visual analog scale.
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